Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction

NCT01726452 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT01726452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01726452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Lead sponsor
Cancer Trials Ireland
Phase
Phase 3
Overall status
Completed
Start date
January 24, 2013
Completion date
August 4, 2022
Enrollment
377 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the oesophago-gastric junction, adenocarcinoma of the oesophagus, junctional tumours, oesophageal cancer, oesophageal tumours